Sacramento, California 95817

  • Primary Sclerosing Cholangitis (PSC)

Purpose:

To demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard endoscopic retrograde cholangiopancreatography (ERCP) with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).


Study summary:

The primary objective of this study is to demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard ERCP with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).


Criteria:

Inclusion Criteria: 1. Confirmed diagnosis of PSC 2. Clinical indication for ERCP per local standard of practice, such as suspicion of potential malignancy based on worsening cholestatic values or clinical presentation (such as itching, cholangitis) or new biliary stricture on trans-abdominal imaging (MRI/MRCP, US or CT) or suspicious cytology 3. Diameter of bile ducts deemed sufficient to accommodate the cholangioscopy system based on imaging performed prior to scheduled ERCP 4. Written informed consent from patient to participate in the study, including compliance with study procedures. Exclusion Criteria: 1. Contraindication for an ERCP or POCS 2. History of liver transplantation 3. Mass/metastasis extrinsic to the bile duct identifiable on diagnostic imaging 4. History of iatrogenic bile duct trauma, including biliary surgery within 6 months of enrollment 5. INR > 1.5 or platelets count < 50,000 6. Age < 18 years 7. Pregnant women or women trying to become pregnant


NCT ID:

NCT03766035


Primary Contact:

Principal Investigator
Johannes Eksteen, MD, PhD
Aspen Woods Clinic

Danielle Vannan, PhD
Phone: 508-683-4139
Email: Danielle.Vannan@bsci.com


Backup Contact:

Email: Srey.Yin@bsci.com
Srey Yin
Phone: 508-683-4162


Location Contact:

Sacramento, California 95817
United States

Christopher Bowlus, MD, PhD

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 26, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.